Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT02267746 Completed - Acne Vulgaris Clinical Trials

A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris

Start date: June 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and therapeutic equivalence of a generic tazarotene foam 0.1% and the reference listed Fabiorâ„¢ (tazarotene foam, 0.1%) in the treatment of acne vulgaris.

NCT ID: NCT02250430 Completed - Acne Vulgaris Clinical Trials

A Phase 1 Study Assessing Local Cutaneous Effects of SB204

Start date: September 2014
Phase: Phase 1
Study type: Interventional

In this study, color (erythema) and pH will be measured on 3 consecutive days after application of 2 doses of SB204 to the cheeks of healthy volunteers.

NCT ID: NCT02249104 Completed - Acne Vulgaris Clinical Trials

A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris

Start date: August 2014
Phase: Phase 4
Study type: Interventional

The goal of this study is to evaluate a complete topical acne regimen consisting of a prescription acne medication (Epiduo® Gel) and an acne-specific cleanser (Cetaphil® DermaControlâ„¢ Foam Wash) and moisturizer with sunscreen (Cetaphil® DermaControlâ„¢ Moisturizer SPF 30) for safety, efficacy and patient satisfaction in student athletes with acne vulgaris.

NCT ID: NCT02242760 Completed - Acne Vulgaris Clinical Trials

P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

Start date: November 2014
Phase: Phase 2
Study type: Interventional

This is a randomized, multi-center, double-blinded study in subjects with moderate to severe acne vulgaris. Subjects eligible to enroll will be treated once or twice daily with 2 concentrations of a topical drug in development or a vehicle. Subjects will be treated for up to 12 weeks.

NCT ID: NCT02219074 Completed - Acne Vulgaris Clinical Trials

Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris

Start date: June 2011
Phase: N/A
Study type: Interventional

Prospective, multicenter study with multiple arms to examine the safety and effectiveness of the Sebacia Acne Treatment System for the treatment of acne vulgaris.

NCT ID: NCT02218034 Completed - Acne Vulgaris Clinical Trials

Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris

Start date: August 2014
Phase: Phase 1
Study type: Interventional

This is a safety, tolerability and pharmacokinetics study of AGN-190168 in subjects with acne vulgaris.

NCT ID: NCT02217228 Completed - Clinical trials for Inflammatory Acne Vulgaris

Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris

Start date: September 2014
Phase: N/A
Study type: Interventional

Prospective, randomized multicenter study to examine the safety and effectiveness of Sebacia microparticles with or without laser in the treatment of moderate to moderately-severe inflammatory acne vulgaris

NCT ID: NCT02216864 Active, not recruiting - Acne Scars Clinical Trials

Effect of Multiple Subcisions on Rolling Acne Scars

Start date: August 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to find out whether the use of multiple subcisions over several visits will improve the appearance of rolling acne scars compared to no treatment. This study was a pilot study designed to determine feasibility of this procedure.

NCT ID: NCT02189629 Completed - Acne Vulgaris Clinical Trials

CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris

Start date: February 23, 2015
Phase: Phase 3
Study type: Interventional

Multi-center, open-label, non-comparative safety and efficacy study with 52 Weeks of treatment on the face and trunk for acne vulgaris.

NCT ID: NCT02180282 Terminated - Acne Clinical Trials

Impact of the M22-IPL Acne Filter on Acne Vulgaris

Start date: July 2014
Phase: N/A
Study type: Interventional

Up to 20 healthy subjects age 15-45 years old ,Skin Phototype I-V,Study will be conducted in 1 site. Primary objectives is to evaluate the efficacy of IPL acne filter treatment for improvement of acne vulgaris as assessed by lesion count.